WO2019151276A1 - アデノシンリン酸およびトラネキサム酸含有外用組成物の変色抑制方法 - Google Patents
アデノシンリン酸およびトラネキサム酸含有外用組成物の変色抑制方法 Download PDFInfo
- Publication number
- WO2019151276A1 WO2019151276A1 PCT/JP2019/003058 JP2019003058W WO2019151276A1 WO 2019151276 A1 WO2019151276 A1 WO 2019151276A1 JP 2019003058 W JP2019003058 W JP 2019003058W WO 2019151276 A1 WO2019151276 A1 WO 2019151276A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- component
- salt
- composition
- acid
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Definitions
- the present application relates to a method for inhibiting discoloration of an external composition containing adenosine phosphoric acid and / or a salt thereof, and tranexamic acid and / or a salt thereof, and a composition in which the discoloration is inhibited.
- Adenosine phosphate is known to have a moisturizing effect and a whitening effect, and cosmetics containing adenosine phosphate are already on the market.
- Tranexamic acid has an antiplasmin action and is incorporated into cosmetics as an active ingredient for improving rough skin and whitening, and many cosmetics are already on the market.
- Patent Document 1 discloses a composition for preventing or improving pigmentation containing adenosine monophosphate and tranexamic acid.
- An object of the present invention is to provide a method for suppressing discoloration over time in a composition containing adenosine phosphate and / or a salt thereof and tranexamic acid and / or a salt thereof, and a composition in which the discoloration is suppressed. It is.
- a specific chelating agent and a specific pH adjuster each contain adenosine phosphate and / or a salt thereof and tranexamic acid and / or a salt thereof.
- the present inventors have found that the discoloration of the composition over time can be suppressed, and have reached the present invention.
- the composition exhibits a sticky feeling due to adenosine phosphate and / or a salt thereof, and the inventors of the present application incorporate a specific component (stickiness improving component) to improve the stickiness. It was found that it is preferable to do this, and among these stickiness improving components, it was found that a specific component does not deteriorate the discoloration over time.
- the present application provides the following: [1] Component (A): adenosine phosphate and / or salt thereof; and component (B): tranexamic acid and / or salt thereof; Containing further, Component (C): a chelating agent selected from edetic acid or a salt thereof, a phosphoric acid compound, and a mixture thereof; and / or Component (D): a pH adjuster that is an organic alkali; The composition for external use containing this. [2] The composition for external use according to [1], wherein the adenosine phosphate and / or salt thereof is adenosine monophosphate and / or salt thereof.
- the phosphoric acid compound is selected from tripolyphosphoric acid or a salt thereof, metaphosphoric acid or a salt thereof, etidronic acid or a salt thereof, phytic acid or a salt thereof, and a mixture thereof.
- the external composition as described.
- component (C) is a phosphoric acid compound selected from tripolyphosphoric acid or a salt thereof, metaphosphoric acid or a salt thereof, etidronic acid or a salt thereof, and a mixture thereof 2.
- component (C) is a phosphoric acid compound selected from tripolyphosphoric acid or a salt thereof, metaphosphoric acid or a salt thereof, etidronic acid or a salt thereof, and a mixture thereof 2.
- composition for external use according to any one of [1] to [6], which contains the component (D) and has a pH of 5.5 to 7.5.
- composition for external use according to any one of [1] to [8], comprising 0.01 to 10% by weight of component (A).
- composition for external use according to any one of [1] to [9], which contains 0.01 to 10% by weight of component (B).
- Component (E) cyclohexanedicarboxylic acid bisethoxydiglycol, diethoxyethyl succinate, highly polymerized polyethylene glycol, highly polymerized silicone, pullulan, polyvinylpyrrolidone, organic fine particles, biosaccharide gum-1, or a mixture thereof;
- Component (C) a chelating agent selected from edetic acid or a salt thereof, a phosphoric acid compound, and a mixture thereof; and / or Component (D): a pH adjuster that is an organic alkali;
- Component (A) adenosine phosphate and / or salt thereof; and component (B): tranexamic acid and / or salt thereof;
- the manufacturing method of the composition for external use including mixing.
- Component (C) a chelating agent selected from edetic acid or a salt thereof, a phosphoric acid compound, and a mixture thereof; and / or Component (D): a pH adjuster that is an organic alkali; Using, Component (A): adenosine phosphate and / or salt thereof; and component (B): tranexamic acid and / or salt thereof; The method of suppressing discoloration of the composition for external use containing this.
- the present invention provides an external composition containing adenosine phosphoric acid and / or a salt thereof, and tranexamic acid and / or a salt thereof, in which discoloration over time is suppressed.
- composition for external use further comprising: Component (C): a chelating agent selected from edetic acid or a salt thereof, a phosphoric acid compound, and a mixture thereof; and / or Component (D): a pH adjuster that is an organic alkali; It is characterized by containing.
- adenosine phosphate as adenosine phosphate, adenosine monophosphate (adenosine 2 ′ monophosphate, adenosine 3 ′ monophosphate, adenosine 5 ′ monophosphate, etc.), adenosine diphosphate (adenosine 5 ′ diphosphate, etc.), Adenosine triphosphate (such as adenosine 5 ′ triphosphate), adenosine 3 ′, 5 ′ cyclic phosphate, etc.), which may be used alone or in any combination of two or more. May be.
- the salt of adenosine phosphate is not particularly limited as long as it can be incorporated into cosmetics, external medicines or quasi drugs.
- adenosine monophosphate salts include alkali metal salts such as sodium salts and potassium salts; alkaline earth metal salts such as calcium salts, magnesium salts and barium salts; basic amino acid salts such as arginine and lysine; Ammonium salts such as ammonium salts and tricyclohexylammonium salts; and various alkanolamine salts such as monoethanolamine salts, diethanolamine salts, triethanolamine salts, monoisopropanolamine salts, diisopropanolamine salts and triisopropanolamine it can.
- the salt of adenosine phosphate may be used alone or in combination of two or more.
- the amount of component (A) contained in the composition of the present application varies depending on the use and form of the external composition, but is usually 0.001 to 10% by weight with respect to the total weight of the external composition, for example. It can be suitably selected from the range. Preferably from 0.01 wt% to 10 wt%, more preferably from 0.1 wt% to 7 wt%, more preferably from 0.5 wt% to 5 wt%, even more preferably from 0.7 wt% to 3 wt% %, And more preferably 1 to 2% by weight.
- the lower limit of the range of the amount of the component (A) contained in the external composition of the present application 0.001% by weight, 0.01% by weight, 0.1% by weight, 0.5% by weight, 0% 7% by weight, 1% by weight, and examples of the upper limit include 1% by weight, 2% by weight, 3% by weight, 5% by weight, 7% by weight, and 10% by weight.
- the upper limit include 1% by weight, 2% by weight, 3% by weight, 5% by weight, 7% by weight, and 10% by weight.
- the salt of tranexamic acid is not particularly limited as long as it can be incorporated into cosmetics, external medicines or quasi drugs.
- the salt of tranexamic acid include alkali metal salts, alkaline earth metal salts, basic amino acid salts, ammonium salts, alkanolamine salts and the like similar to adenosine phosphoric acid. These salts of tranexamic acid may be used alone or in combination of two or more.
- the amount of the component (B) contained in the composition of the present application varies depending on the application and form of the external composition, but is usually 0.001 to 10% by weight with respect to the total weight of the external composition, for example. It can be suitably selected from the range. Preferably from 0.01 wt% to 10 wt%, more preferably from 0.1 wt% to 7 wt%, more preferably from 0.5 wt% to 5 wt%, even more preferably from 0.7 wt% to 3 wt% %, And more preferably 1 to 2% by weight.
- the lower limit of the range of the amount of the component (B) contained in the external composition of the present application 0.001% by weight, 0.01% by weight, 0.1% by weight, 0.5% by weight, 0% 7% by weight, 1% by weight, and examples of the upper limit include 1% by weight, 2% by weight, 3% by weight, 5% by weight, 7% by weight, and 10% by weight.
- the upper limit include 1% by weight, 2% by weight, 3% by weight, 5% by weight, 7% by weight, and 10% by weight.
- the chelating agent for component (C) examples include edetic acid or a salt thereof, and a phosphoric acid compound (for example, tripolyphosphoric acid or a salt thereof, metaphosphoric acid or a salt thereof, etidronic acid or a salt thereof, and phytic acid or a salt thereof). These chelating agents may be used alone or in combination of two or more. Preferable examples of the chelating agent for component (C) include tripolyphosphoric acid or a salt thereof, metaphosphoric acid or a salt thereof, and etidronic acid or a salt thereof. In the composition of the present application, a chelating agent other than the component (C) may be used as long as discoloration over time does not become a problem.
- a chelating agent other than the component (C) may be used as long as discoloration over time does not become a problem.
- salts of edetic acid include EDTA-2K, EDTA-2Na, EDTA-3K, EDTA-3Na, EDTA-4Na, EDTA (Ca / 2Na), etc., and these may be used alone, You may use it in combination of 2 or more types arbitrarily.
- Preferred examples of edetic acid or its salts include EDTA, EDTA-2Na, EDTA-3Na, and EDTA-4Na.
- tripolyphosphoric acid salts such as alkali metal salts, alkaline earth metal salts, basic amino acid salts, ammonium salts, alkanolamines similar to adenosine phosphoric acid Examples include salts. These salts may be used alone or in combination of two or more.
- tripolyphosphate examples include Na tripolyphosphate and K tripolyphosphate.
- Preferred examples of the metaphosphate include Na metaphosphate and K metaphosphate.
- Preferred examples of etidronate include etidronate 3Na, etidronate 4K, and etidronate 4Na.
- Preferable examples of phytate include calcium phytate and sodium phytate.
- the lower limit of the range of the weight ratio of the component (C) when the total weight of the component (A) and the component (B) contained in the external composition of the present application is 1, 0.00001, 0 0.0001, 0.0005, 0.001, 0.01, 0.05, and examples of the upper limit include 0.05, 0.1, 0.2, 0.5,
- a preferable example of the range can be indicated by a combination of the lower limit value and the upper limit value.
- the amount of the component (C) that can be contained in the composition of the present application can be appropriately selected from the range of usually 0.0001 to 2% by weight with respect to the total weight of the composition for external use. Preferably it is 0.0002 to 1.5% by weight, more preferably 0.0005 to 1% by weight, more preferably 0.001 to 0.5% by weight.
- the lower limit of the range of the amount of the component (C) that can be contained in the external composition of the present application 0.0001 wt%, 0.0002 wt%, 0.0005 wt%, 0.001 wt%, 0.01% by weight, 0.1% by weight, 0.2% by weight
- examples of the upper limit include 0.2% by weight, 0.5% by weight, 1% by weight, 2% by weight
- a preferable example of the range can be indicated by a combination of the lower limit value and the upper limit value.
- Examples of the pH adjuster that is an organic alkali of component (D) include aminohydroxymethylpropanediol, aminomethylpropanol, aminomethylpropanediol, arginine, and triethanolamine. These pH adjusters may be used alone or in combination of two or more. Examples of pH adjusters that are preferred organic alkalis include aminohydroxymethylpropanediol, aminomethylpropanediol, and arginine.
- the pH adjuster of component (D) for adjusting the pH of the external composition of the present application.
- the preferred pH of the external composition of the present application varies depending on the use of the composition, etc., and examples thereof include pH 5.5 to 7.5.
- a pH adjusting agent other than the component (D) may be used as long as discoloration over time does not become a problem.
- the amount of the component (D) is not particularly limited as long as the discoloration of the composition over time is suppressed, the amount of the component (A), the type and amount of other optional components, and the composition
- the lower limit value of the range of the weight ratio of the component (C) when the weight of the component (A) contained in the external composition of the present application is 1, 0.0001, 0.001, 0.01, 0.1
- examples of the upper limit include 0.1, 0.5, 1, 2, 3, and 4.
- a preferable example of the range can be indicated by a combination of the lower limit and the upper limit. .
- the present application further includes component (E): cyclohexanedicarboxylic acid bisethoxydiglycol, diethoxyethyl succinate, highly polymerized polyethylene glycol (for example, having a freezing point of 40 ° C. or higher), and highly polymerized silicone (for example, kinematic viscosity is 6000 mm 2 / s).
- component (E) cyclohexanedicarboxylic acid bisethoxydiglycol, diethoxyethyl succinate, highly polymerized polyethylene glycol (for example, having a freezing point of 40 ° C. or higher), and highly polymerized silicone (for example, kinematic viscosity is 6000 mm 2 / s).
- pullulan polyvinylpyrrolidone
- organic fine particles for example, silica, polymethyl methacrylate, talc, and urethane
- biosaccharide gum-1 or a mixture thereof. It is possible to provide a composition with
- the lower limit of the range of the weight ratio of the component (E) when the weight of the component (A) contained in the external composition of the present application is 1, 0.01, 0.03, 0.05, 0.1, 0.5, 0.7, and 1 are listed
- examples of the upper limit include 1.5, 2, 3, 5, 10, 20, 25, and 30. It can be indicated by a combination of the lower limit value and the upper limit value.
- the amount of the component (E) contained in the composition of the present application varies depending on the type of the component (E) used and the application and form of the external composition, but for example, the total weight of the external composition On the other hand, it can be appropriately selected from the range of usually 0.001 to 10% by weight. Preferably from 0.01 wt% to 10 wt%, more preferably from 0.1 wt% to 7 wt%, more preferably from 0.5 wt% to 5 wt%, even more preferably from 0.7 wt% to 2 wt% % Is exemplified.
- the lower limit of the range of the amount of the component (E) contained in the external composition of the present application 0.001% by weight, 0.01% by weight, 0.1% by weight, 0.5% by weight, 0% 7% by weight, 1% by weight, and examples of the upper limit include 1% by weight, 2% by weight, 3% by weight, 5% by weight, 7% by weight, and 10% by weight.
- the upper limit include 1% by weight, 2% by weight, 3% by weight, 5% by weight, 7% by weight, and 10% by weight.
- Each component that can be blended in the composition of the present application may be in the form of a hydrate.
- composition for external use of the present application can be prepared in various forms by combining pharmaceutically or cosmetically acceptable bases and carriers in addition to the above components.
- pharmaceutically or cosmetically acceptable base and carrier conventionally known ones can be used.
- the composition of the present invention may be blended with various known ingredients that are blended in an external composition applied to the skin and mucous membranes of cosmetics, external medicines and quasi drugs, if necessary. it can.
- Such components include surfactants, pigments (dyes, pigments), fragrances, preservatives, bactericides (antibacterial agents), thickeners, antioxidants, metal sequestering agents, cooling agents, deodorants, Moisturizer, UV absorber, UV scattering agent, vitamins, plant extract, skin astringent, anti-inflammatory agent (anti-inflammatory agent), whitening agent, cell activator, vasodilator, blood circulation promoter, skin function enhancer, etc. Can be mentioned.
- the external composition of the present application may optionally further include water, ethanol, glycerin, BG, 1,2-pentanediol, menthol, POE hydrogenated castor oil, phenoxyethanol, a fragrance, and a mixture thereof.
- the external composition of the present invention can be used as an external composition applied or sprayed on the skin.
- the composition of the present invention can be used as an external preparation (outer preparation) for cosmetics, external medicines or external quasi drugs.
- the form of the composition for external use of the present invention is not particularly limited as long as it can be applied to the skin.
- it is paste, mousse, gel, liquid, emulsion, suspension, cream, ointment, etc. , Solid, sheet, aerosol, spray, and liniment.
- cosmetics lotions; emulsions such as emollient emulsions, milky lotions, nourishing emulsions, cleansing emulsions; creams such as emollient creams, massage creams, cleansing creams, makeup creams; lip creams, etc. Can do.
- Chelating agent I for suppressing discoloration Mix the components shown in the table below, adjust the pH to 5.5 to 7.5 with potassium hydroxide, prepare comparative examples and formulation examples, fill in glass sealed containers and store at 60 ° C for 2 weeks. did. After the storage, visually check for discoloration, A: No discoloration at all; ⁇ : Almost no discoloration; ⁇ : Slightly discolored; ⁇ : remarkably discolored; As evaluated. The results are shown in the table below.
- Chelating agent II for suppressing discoloration Mix the components shown in the table below, adjust the pH to 5.5 to 7.5 with potassium hydroxide, prepare comparative examples and formulation examples, fill in glass sealed containers and store at 50 ° C for 6 months. did. Check whether there is any discoloration visually after the storage. A: No discoloration at all; ⁇ : Almost no discoloration; ⁇ : Slightly discolored; ⁇ : remarkably discolored; As evaluated. The results are shown in the table below.
- the comparative examples and the respective formulation examples are moisturizers (glycerin, butylene glycol, and 1,2-pentanediol), touch improvers (cycloethoxydicarboxylate bisethoxydiglycol), preservatives (phenoxyethanol), A solubilizer (POE hydrogenated castor oil) and a fragrance were each contained in the same amount.
- the cyclohexanedicarboxylate bisethoxydiglycol was also tested for 1%, 1.5%, or 2% by weight. The result was the same as 0.5% by weight in Table 4.
- Silica was also tested for 2.5%, 3%, 3.5%, 4%, 4.5%, and 5% by weight. The result was the same as 2% by weight in Table 4.
- Polymethylmethacrylate was also tested for 2.5%, 3%, 3.5%, 4%, 4.5%, and 5% by weight. The result was the same as 2% by weight in Table 4.
- PEG / PPG / polybutylene glycol-8 / 5/3 glycerin was also tested for 1.5 wt%, 2 wt%, 2.5 wt% and 3 wt%. The result was the same as 1% by weight in Table 4.
- Polyglycerin was also tested for 1.5 wt%, 2 wt%, 2.5 wt%, 3 wt%, 3.5 wt%, 4 wt%, 4.5 wt% and 5 wt%. The result was the same as 1% by weight in Table 4.
- Polyoxypropylene diglyceryl ether was also tested for 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, and 5% by weight. Did. The result was the same as 1% by weight in Table 4.
- Formulation Example 41 Lotion ⁇ Manufacturing method> A water-soluble component was dissolved in purified water according to a conventional method (main phase). A water-insoluble component was added to the main phase after mixing with a surfactant to obtain a skin lotion.
- Formulation Example 42 Cloudy lotion ⁇ Contained ingredient>% by weight Adenosine phosphate 0.5 Tranexamic acid 3 Glycerin 1 Dipropylene glycol 4 Polyethylene glycol 20000 1 Ethanol 7 Polyoxyethylene hydrogenated castor oil 0.4 Polyoxyethylene glyceryl isostearate 0.2 Pentaerythrityl tetraethylhexanoate 0.2 Sodium tripolyphosphate 0.1 Aminohydroxymethylpropanediol Appropriate amount of preservative Appropriate amount of perfume Appropriate amount of purified water Residue ⁇ Production method> A water phase was prepared by dissolving water-soluble components in purified water according to a conventional method. The water-insoluble component was gradually added to the aqueous phase after heating and mixing with the surfactant to obtain a cloudy lotion.
- Formulation Example 43 Cosmetic liquid ⁇ formulation component>% by weight Adenosine phosphate 1 Tranexamic acid 2 Ascorbic acid glucoside 2 Glycerin 8 Sorbitol 2 Oligohyaluronic acid 0.1 Xanthan gum 0.2 Quince seed gum 0.1 Polyoxyethylene hydrogenated castor oil 0.3 Etidronic acid 0.03 Aminomethylpropanol Appropriate amount of preservative Appropriate amount of antioxidant Appropriate amount of perfume Appropriate amount of purified water Residue ⁇ Production method> A water-soluble component was dissolved in purified water according to a conventional method (main phase). The water-insoluble component was added to the main phase after mixing with the surfactant to obtain a cosmetic liquid.
- Formulation Example 44 Gel serum ⁇ Manufacturing method> After dispersing the carbomer in purified water, other water-soluble components were dissolved by heating (main phase). The water-insoluble component was mixed with a surfactant, added to the main phase, thoroughly mixed thoroughly, and degassed to obtain the desired gel cosmetic liquid.
- Formulation Example 45 Gelled emulsion ⁇ formulation component> wt% Adenosine phosphate 0.5 Tranexamic acid 2 Carboxyvinyl polymer 0.2 Acrylic acid / alkyl methacrylate copolymer 0.5 Glycerin 6 Dipropylene glycol 4 Cyclopentasiloxane 5 Dimethicone 1 Dimethiconol 0.2 Aminopropyl dimethicone 0.1 Liquid isoparaffin 2 Sodium metaphosphate 0.4 Arginine Appropriate amount of preservative Appropriate amount of antioxidant Appropriate amount of perfume Appropriate amount of purified water Residue ⁇ Production method> Dissolve the water-soluble polymer and other water-soluble components in purified water with heating to prepare an aqueous phase, disperse and mix the oil phase in which oil-soluble components are heated and dissolved with a disper, emulsify, and mix thoroughly. After deaeration, the desired gel emulsion was
- Emulsion ⁇ Manufacturing method> Dissolve the water-soluble polymer and other water-soluble components in purified water with heating to prepare an aqueous phase, disperse and mix the oil phase in which oil-soluble components are heated and dissolved with a disper, emulsify, and mix thoroughly. After deaeration, the desired emulsion was obtained.
- Formulation Example 47 Cream ⁇ Composition Component> Weight% Adenosine phosphate 1.5 Tranexamic acid 2 Glycerin 5 Trehalose 1 Polyisoethylene glyceryl monoisostearate 2 Glyceryl stearate 3 Sodium stearoyl glutamate 0.5 Triethylhexanoin 8 Liquid paraffin 7 Vaseline 1 Dimethicone 0.5 Behenyl alcohol 3 Stearic acid 2 Polyvinyl alcohol 0.5 Hydroxyethyl cellulose 0.5 Phytic acid 0.4 Aminohydroxymethylpropanediol Appropriate Preservative Appropriate Antioxidant Appropriate Perfume Appropriate Purified Water Residue ⁇ Production Method> Dissolve the water-soluble polymer and other water-soluble components in purified water with heating to prepare an aqueous phase, disperse and mix the oil phase in which oil-soluble components are heated and dissolved with a disper, emulsify, and mix thoroughly.
Abstract
Description
[1]
成分(A):アデノシンリン酸および/またはその塩;および
成分(B):トラネキサム酸および/またはその塩;
を含有し、
さらに、
成分(C):エデト酸またはその塩、リン酸化合物、およびそれらの混合物から選択されるキレート剤;および/または
成分(D):有機性アルカリであるpH調整剤;
を含有する、外用組成物。
[2] 該アデノシンリン酸および/またはその塩がアデノシン一リン酸および/またはその塩である、[1]に記載の外用組成物。
をさらに含有する、[1]~[10]のいずれか1項に記載の外用組成物。
成分(C):エデト酸またはその塩、リン酸化合物、およびそれらの混合物から選択されるキレート剤;および/または
成分(D):有機性アルカリであるpH調整剤;
の存在下に、
成分(A):アデノシンリン酸および/またはその塩;および
成分(B):トラネキサム酸および/またはその塩;
を混合することを含む、外用組成物の製造方法。
成分(C):エデト酸またはその塩、リン酸化合物、およびそれらの混合物から選択されるキレート剤;および/または
成分(D):有機性アルカリであるpH調整剤;
を用いて、
成分(A):アデノシンリン酸および/またはその塩;および
成分(B):トラネキサム酸および/またはその塩;
を含有する外用組成物の変色を抑制する方法。
成分(A):アデノシンリン酸および/またはその塩;および
成分(B):トラネキサム酸および/またはその塩;
を含有する外用組成物に関し、該外用組成物はさらに、
成分(C):エデト酸またはその塩、リン酸化合物、およびそれらの混合物から選択されるキレート剤;および/または
成分(D):有機性アルカリであるpH調整剤;
を含有することを特徴とするものである。
さらに、本願の外用組成物に含まれる成分(A)の量の範囲の下限値の例として、0.001重量%、0.01重量%、0.1重量%、0.5重量%、0.7重量%、1重量%が挙げられ、上限値の例として、1重量%、2重量%、3重量%、5重量%、7重量%、10重量%が挙げられ、当該範囲の好ましい例は該下限値と該上限値の組合せにより示されうる。
さらに、本願の外用組成物に含まれる成分(B)の量の範囲の下限値の例として、0.001重量%、0.01重量%、0.1重量%、0.5重量%、0.7重量%、1重量%が挙げられ、上限値の例として、1重量%、2重量%、3重量%、5重量%、7重量%、10重量%が挙げられ、当該範囲の好ましい例は該下限値と該上限値の組合せにより示されうる。
メタリン酸塩の好ましい例として、メタリン酸Naおよびメタリン酸Kが挙げられる。
エチドロン酸塩の好ましい例として、エチドロン酸3Na、エチドロン酸4K、およびエチドロン酸4Naが挙げられる。
フィチン酸塩の好ましい例として、フィチン酸カルシウムおよびフィチン酸ナトリウムが挙げられる。
さらに、本願の外用組成物に含まれうる成分(C)の量の範囲の下限値の例として、0.0001重量%、0.0002重量%、0.0005重量%、0.001重量%、0.01重量%、0.1重量%、0.2重量%が挙げられ、上限値の例として、0.2重量%、0.5重量%、1重量%、2重量%が挙げられ、当該範囲の好ましい例は該下限値と該上限値の組合せにより示されうる。
さらに、本願の外用組成物に含まれる成分(A)の重量を1としたときの成分(E)の重量比の範囲の下限値の例として、0.01、0.03、0.05、0.1、0.5、0.7、1が挙げられ、上限値の例として、1.5、2、3、5、10、20、25、30が挙げられ、当該範囲の好ましい例は該下限値と該上限値の組合せにより示されうる。
さらに、本願の外用組成物に含まれる成分(E)の量の範囲の下限値の例として、0.001重量%、0.01重量%、0.1重量%、0.5重量%、0.7重量%、1重量%が挙げられ、上限値の例として、1重量%、2重量%、3重量%、5重量%、7重量%、10重量%が挙げられ、当該範囲の好ましい例は該下限値と該上限値の組合せにより示されうる。
下表に示す各成分を混合し、水酸化カリウムでpH5.5~7.5に調整して、比較例および各処方例を調製し、ガラス製密閉容器に充填して60℃に2週間保存した。
当該保存後に変色の有無を目視により、
◎:全く変色なし;
○:ほとんど変色なし;
△:やや変色した;
×:著しく変色した;
として評価した。結果を下表に示す。
下表に示す各成分を混合し、水酸化カリウムでpH5.5~7.5に調整して、比較例および各処方例を調製し、ガラス製密閉容器に充填して50℃に6箇月保存した。
当該保存後に目視により変色の有無を、
◎:全く変色なし;
○:ほとんど変色なし;
△:やや変色した;
×:著しく変色した;
として評価した。結果を下表に示す。
表中、比較例および各処方例は、その他成分として保湿剤(グリセリン、ブチレングリコール、および1,2-ペンタンジオール)、感触改良剤(シクロヘキサンジカルボン酸ビスエトキシジグリコール)、防腐剤(フェノキシエタノール)、可溶化剤(POE硬化ヒマシ油)、および香料をそれぞれ、同量含有した。
下表に示す各成分を混合し、比較例および各処方例を調製し(いずれもpH5.5~7.5)、ガラス製密閉容器に充填して60℃に2週間保存した。
当該保存後に変色の有無を目視により、
◎:全く変色なし;
○:ほとんど変色なし;
△:やや変色した;
×:著しく変色した;
として評価した。結果を下表に示す。
下表に示す各成分を混合し、水酸化カリウムでpH5.5~7.5に調整して、比較例および各処方例を調製した。その他成分として、防腐剤(フェノキシエタノール)、可溶化剤、香料を含有した。
3名のパネリストにより、比較例および各処方例(0.5g)を顔に塗布し、べたつき感について、比較例と比べて
◎:改善した;
○:やや改善した
×:改善しなかった
として評価した。結果を表4に示す。
比較例および各処方例を、ガラス製密閉容器に充填して50℃に1週間または40℃に6箇月保存した。
当該保存後に目視により変色の有無を、
◎:全く変色なし;
○:ほとんど変色なし;
△:やや変色した;
×:著しく変色した;
として評価した。結果を表4に示す。
ポリメタクリル酸メチルについて、2.5重量%、3重量%、3.5重量%、4重量%、4.5重量%、5重量%についても試験をした。結果は表4の2重量%と同じであった。
<配合成分>重量%
アデノシンリン酸 0.5
トラネキサム酸 3
グリセリン 1
ジプロピレングリコール 4
ポリエチレングリコール20000 1
エタノール 7
ポリオキシエチレン硬化ヒマシ油 0.4
イソステアリン酸ポリオキシエチレングリセリル 0.2
テトラエチルヘキサン酸ペンタエリスリチル 0.2
トリポリリン酸ナトリウム 0.1
アミノヒドロキシメチルプロパンジオール 適量
防腐剤 適量
香料 適量
精製水 残余
<製造方法>
定法に従って精製水に水溶性成分を溶解し,水相を調製した。水不溶性成分は,界面活性剤と加熱混合後に水相に徐々に添加し,白濁化粧水を得た。
<配合成分>重量%
アデノシンリン酸 1
トラネキサム酸 2
アスコルビン酸グルコシド 2
グリセリン 8
ソルビトール 2
オリゴヒアルロン酸 0.1
キサンタンガム 0.2
クインスシードガム 0.1
ポリオキシエチレン硬化ヒマシ油 0.3
エチドロン酸 0.03
アミノメチルプロパノール 適量
防腐剤 適量
酸化防止剤 適量
香料 適量
精製水 残余
<製造方法>
定法に従って,精製水に水溶性成分を溶解した(主相)。水不溶性成分は界面活性剤と混合後に主相に添加し,美容液を得た。
<製造方法>
精製水にカルボマーを分散した後,その他の水溶性成分を加温溶解した(主相)。水不溶性成分は界面活性剤と混合して主相に添加して十分に均一混合して脱気後,目的のジェル状美容液を得た。
<配合成分>重量%
アデノシンリン酸 0.5
トラネキサム酸 2
カルボキシビニルポリマー 0.2
アクリル酸・メタクリル酸アルキル共重合体 0.5
グリセリン 6
ジプロピレングリコール 4
シクロペンタシロキサン 5
ジメチコン 1
ジメチコノール 0.2
アミノプロピルジメチコン 0.1
流動イソパラフィン 2
メタリン酸ナトリウム 0.4
アルギニン 適量
防腐剤 適量
酸化防止剤 適量
香料 適量
精製水 残余
<製造方法>
精製水に水溶性高分子とその他の水溶性成分を加温溶解し,水相を調製し,油溶性成分を加温溶解した油相をディスパーで分散混合し,乳化し,十分均一に混合して脱気後,目的のジェル乳液を得た。
<製造方法>
精製水に水溶性高分子とその他の水溶性成分を加温溶解し,水相を調製し,油溶性成分を加温溶解した油相をディスパーで分散混合し,乳化し,十分均一に混合して脱気後,目的の乳液を得た。
<配合成分>重量%
アデノシンリン酸 1.5
トラネキサム酸 2
グリセリン 5
トレハロース 1
モノイソステアリン酸ポリオキシエチレングルセリル 2
ステアリン酸グリセリル 3
ステアロイルグルタミン酸ナトリウム 0.5
トリエチルヘキサノイン 8
流動パラフィン 7
ワセリン 1
ジメチコン 0.5
ベヘニルアルコール 3
ステアリン酸 2
ポリビニルアルコール 0.5
ヒドロキシエチルセルロース 0.5
フィチン酸 0.4
アミノヒドロキシメチルプロパンジオール 適量
防腐剤 適量
酸化防止剤 適量
香料 適量
精製水 残余
<製造方法>
精製水に水溶性高分子とその他の水溶性成分を加温溶解し,水相を調製し,油溶性成分を加温溶解した油相をディスパーで分散混合し,乳化し,十分均一に混合して脱気後,目的のクリームを得た。
Claims (13)
- 成分(A):アデノシンリン酸および/またはその塩;および
成分(B):トラネキサム酸および/またはその塩;
を含有し、
さらに、
成分(C):エデト酸またはその塩、リン酸化合物、およびそれらの混合物から選択されるキレート剤;および/または
成分(D):有機性アルカリであるpH調整剤;
を含有する、外用組成物。 - 該アデノシンリン酸および/またはその塩がアデノシン一リン酸および/またはその塩である、請求項1に記載の外用組成物。
- 該リン酸化合物が、トリポリリン酸またはその塩、メタリン酸またはその塩、エチドロン酸またはその塩、フィチン酸またはその塩、およびそれらの混合物から選択される、請求項1または2に記載の外用組成物。
- 成分(C)が、トリポリリン酸またはその塩、メタリン酸またはその塩、エチドロン酸またはその塩、およびそれらの混合物から選択されるリン酸化合物である、請求項1~3のいずれか1項に記載の外用組成物。
- 成分(D)が、アミノヒドロキシメチルプロパンジオール、アミノメチルプロパノール、アミノメチルプロパンジオール、アルギニン、トリエタノールアミン、およびそれらの混合物から選択される、請求項1~4のいずれか1項に記載の外用組成物。
- 成分(A)と成分(B)の合計に対し成分(C)が、(成分(A)+成分(B)):成分(C)=1:0.0001~0.5の重量比で含有される、請求項1~5のいずれか1項に記載の外用組成物。
- 成分(D)を含有し、かつ、pHが5.5~7.5である、請求項1~6のいずれか1項に記載の外用組成物。
- 成分(A)に対し成分(D)が、成分(A):成分(D)=1:0.00001~4の重量比で含有される、請求項1~7のいずれか1項に記載の外用組成物。
- 成分(A)を0.01~10重量%含有する、請求項1~8のいずれか1項に記載の外用組成物。
- 成分(B)を0.01~10重量%含有する、請求項1~9のいずれか1項に記載の外用組成物。
- 成分(E):シクロヘキサンジカルボン酸ビスエトキシジグリコール、コハク酸ジエトキシエチル、高重合ポリエチレングリコール、高重合シリコーン、プルラン、ポリビニルピロリドン、有機微粒子、ビオサッカリドガム-1、またはその混合物;
をさらに含有する、請求項1~10のいずれか1項に記載の外用組成物。 - 成分(C):エデト酸またはその塩、リン酸化合物、およびそれらの混合物から選択されるキレート剤;および/または
成分(D):有機性アルカリであるpH調整剤;
の存在下に、
成分(A):アデノシンリン酸および/またはその塩;および
成分(B):トラネキサム酸および/またはその塩;
を混合することを含む、外用組成物の製造方法。 - 成分(C):エデト酸またはその塩、リン酸化合物、およびそれらの混合物から選択されるキレート剤;および/または
成分(D):有機性アルカリであるpH調整剤;
を用いて、
成分(A):アデノシンリン酸および/またはその塩;および
成分(B):トラネキサム酸および/またはその塩;
を含有する外用組成物の変色を抑制する方法。
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG11202007228WA SG11202007228WA (en) | 2018-01-31 | 2019-01-30 | Method for suppressing discoloration of external composition containing adenosine phosphate and tranexamic acid |
AU2019214050A AU2019214050A1 (en) | 2018-01-31 | 2019-01-30 | Method for suppressing discoloration of external composition containing adenosine phosphate and tranexamic acid |
EP19748241.7A EP3747424A4 (en) | 2018-01-31 | 2019-01-30 | METHOD OF SUPPRESSING THE COLORING OF AN EXTERNAL COMPOSITION WITH ADENOSINE PHOSPHATE AND TRANEXAMIC ACID |
CN201980022694.XA CN111936116B (zh) | 2018-01-31 | 2019-01-30 | 含有腺苷磷酸和凝血酸的外用组合物的变色抑制方法 |
US16/966,259 US20200375867A1 (en) | 2018-01-31 | 2019-01-30 | Method for suppressing discoloration of external composition containing adenosine phosphate and tranexamic acid |
JP2019569151A JP7307685B2 (ja) | 2018-01-31 | 2019-01-30 | アデノシンリン酸およびトラネキサム酸含有外用組成物の変色抑制方法 |
KR1020207024423A KR20200115565A (ko) | 2018-01-31 | 2019-01-30 | 아데노신인산 및 트라넥삼산 함유 외용 조성물의 변색 억제 방법 |
PH12020551154A PH12020551154A1 (en) | 2018-01-31 | 2020-07-30 | Method for suppressing discoloration of external composition containing adenosine phosphate and tranexamic acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018-015486 | 2018-01-31 | ||
JP2018015486 | 2018-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019151276A1 true WO2019151276A1 (ja) | 2019-08-08 |
Family
ID=67478318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2019/003058 WO2019151276A1 (ja) | 2018-01-31 | 2019-01-30 | アデノシンリン酸およびトラネキサム酸含有外用組成物の変色抑制方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20200375867A1 (ja) |
EP (1) | EP3747424A4 (ja) |
JP (1) | JP7307685B2 (ja) |
KR (1) | KR20200115565A (ja) |
CN (1) | CN111936116B (ja) |
AU (1) | AU2019214050A1 (ja) |
PH (1) | PH12020551154A1 (ja) |
SG (1) | SG11202007228WA (ja) |
TW (1) | TWI815855B (ja) |
WO (1) | WO2019151276A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6983962B1 (ja) * | 2020-08-12 | 2021-12-17 | 株式会社 資生堂 | アルカリ性化粧料 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114795996B (zh) * | 2022-04-08 | 2023-08-29 | 广东先强药业有限公司 | 一种含有核苷类成分的组合物及其应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003081840A (ja) * | 2001-07-04 | 2003-03-19 | Rohto Pharmaceut Co Ltd | 清涼化方法、清涼化剤および外用組成物 |
JP2003206224A (ja) * | 2002-01-08 | 2003-07-22 | Otsuka Pharmaceut Co Ltd | 外用組成物 |
WO2006033343A1 (ja) | 2004-09-22 | 2006-03-30 | Otsuka Pharmaceutical Co., Ltd. | 色素沈着予防又は改善用組成物 |
US20060183708A1 (en) * | 2002-11-29 | 2006-08-17 | Bioderm Research | Topical Delivery of Trace Metals for Enzyme Modulation |
JP2014062077A (ja) * | 2012-09-24 | 2014-04-10 | Kyoei Kagaku Kogyo Kk | 化粧料用組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3483988B2 (ja) * | 1995-06-01 | 2004-01-06 | 株式会社資生堂 | 皮膚外用剤 |
JP5514268B2 (ja) * | 2004-09-22 | 2014-06-04 | 大塚製薬株式会社 | 色素沈着予防又は改善剤 |
AU2014378413C1 (en) | 2014-01-17 | 2020-05-28 | Otsuka Pharmaceutical Co., Ltd. | Emulsion composition for skin |
CN104434766A (zh) * | 2014-11-27 | 2015-03-25 | 沈阳源康医疗器械有限公司 | 一种含蛹虫草成分的调理喷雾及其制备方法 |
-
2019
- 2019-01-30 JP JP2019569151A patent/JP7307685B2/ja active Active
- 2019-01-30 WO PCT/JP2019/003058 patent/WO2019151276A1/ja unknown
- 2019-01-30 KR KR1020207024423A patent/KR20200115565A/ko unknown
- 2019-01-30 SG SG11202007228WA patent/SG11202007228WA/en unknown
- 2019-01-30 AU AU2019214050A patent/AU2019214050A1/en not_active Abandoned
- 2019-01-30 TW TW108103489A patent/TWI815855B/zh active
- 2019-01-30 EP EP19748241.7A patent/EP3747424A4/en active Pending
- 2019-01-30 US US16/966,259 patent/US20200375867A1/en not_active Abandoned
- 2019-01-30 CN CN201980022694.XA patent/CN111936116B/zh active Active
-
2020
- 2020-07-30 PH PH12020551154A patent/PH12020551154A1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003081840A (ja) * | 2001-07-04 | 2003-03-19 | Rohto Pharmaceut Co Ltd | 清涼化方法、清涼化剤および外用組成物 |
JP2003206224A (ja) * | 2002-01-08 | 2003-07-22 | Otsuka Pharmaceut Co Ltd | 外用組成物 |
US20060183708A1 (en) * | 2002-11-29 | 2006-08-17 | Bioderm Research | Topical Delivery of Trace Metals for Enzyme Modulation |
WO2006033343A1 (ja) | 2004-09-22 | 2006-03-30 | Otsuka Pharmaceutical Co., Ltd. | 色素沈着予防又は改善用組成物 |
JP2014062077A (ja) * | 2012-09-24 | 2014-04-10 | Kyoei Kagaku Kogyo Kk | 化粧料用組成物 |
Non-Patent Citations (1)
Title |
---|
See also references of EP3747424A4 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6983962B1 (ja) * | 2020-08-12 | 2021-12-17 | 株式会社 資生堂 | アルカリ性化粧料 |
JP2022032549A (ja) * | 2020-08-12 | 2022-02-25 | 株式会社 資生堂 | アルカリ性化粧料 |
Also Published As
Publication number | Publication date |
---|---|
AU2019214050A1 (en) | 2020-08-27 |
PH12020551154A1 (en) | 2021-06-07 |
TWI815855B (zh) | 2023-09-21 |
US20200375867A1 (en) | 2020-12-03 |
SG11202007228WA (en) | 2020-08-28 |
TW201940157A (zh) | 2019-10-16 |
CN111936116A (zh) | 2020-11-13 |
JPWO2019151276A1 (ja) | 2021-01-28 |
CN111936116B (zh) | 2023-06-20 |
JP7307685B2 (ja) | 2023-07-12 |
KR20200115565A (ko) | 2020-10-07 |
EP3747424A1 (en) | 2020-12-09 |
EP3747424A4 (en) | 2022-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3409264B1 (en) | Alpha-gel formation composition, external skin care composition using alpha-gel formation composition, and alpha-gel composition using alpha-gel formation composition | |
JP5550863B2 (ja) | 化粧料 | |
JP7307685B2 (ja) | アデノシンリン酸およびトラネキサム酸含有外用組成物の変色抑制方法 | |
JP2010024204A (ja) | 皮膚外用剤 | |
WO2019151275A1 (ja) | アデノシンリン酸含有組成物のべたつき改善方法 | |
TW202308591A (zh) | 化妝料 | |
WO2020218547A1 (ja) | アデノシンリン酸を含有するo/w型高粘度乳化組成物 | |
US8173112B2 (en) | Emulsified composition for hair | |
JP2005132828A (ja) | 外用組成物 | |
KR101904708B1 (ko) | 발포성 클렌징용 화장료 조성물 | |
US20220395436A1 (en) | Gel composition with high oil content, the preparation method and the use of the same | |
KR20220004109A (ko) | 아데노신인산을 함유하는 o/w형 저점도 유화 조성물 | |
JP2020147538A (ja) | 乳液状皮膚化粧料 | |
EP1380283B1 (en) | Cosmetic composition | |
JP2000191499A (ja) | 保湿用皮膚化粧料 | |
JP2018162236A (ja) | ネイルトリートメント用組成物及びネイルトリートメント製品 | |
JP2023108855A (ja) | 皮膚化粧料組成物 | |
CN118043056A (en) | Liquid skin external composition | |
JP2021123587A (ja) | 外用医薬組成物 | |
JP2023128960A (ja) | 皮膚洗浄剤組成物 | |
JP2021123586A (ja) | 外用医薬組成物 | |
JP2022138175A (ja) | 皮膚外用組成物 | |
JP2002161018A (ja) | 化粧料 | |
KR20240044028A (ko) | 불소화합물, 비이온성 계면활성제 및 양쪽성 계면활성제를 안정적으로 포함하는 수중유형 화장료 조성물 | |
JP2022150080A (ja) | 水中油型乳化組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19748241 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2019569151 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20207024423 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2019214050 Country of ref document: AU Date of ref document: 20190130 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2019748241 Country of ref document: EP Effective date: 20200831 |